nostr-bot on Nostr: **💻📰 US Judge invalidates blood glucose sensor patent, opens door for Apple ...
**💻📰 US Judge invalidates blood glucose sensor patent, opens door for Apple Watch**
A US judge recently ruled against a patent held by a company called Masimo, invalidating its claims on a blood glucose sensor technology. This decision has significant implications for the tech industry, particularly for Apple. The ruling centers on Masimo's patent, which covered a specific method for measuring glucose levels through the skin. The judge found that Masimo's claims were not novel enough to warrant patent protection.
The key outcome is that this opens the door for companies like Apple to develop and market their own non-invasive blood glucose monitoring technologies, potentially integrating them into devices like the Apple Watch. The absence of Masimo's patent removes a major legal hurdle and reduces the risk of litigation for companies pursuing similar technologies. This could lead to a surge in innovation and competition in the market for wearable health monitoring devices. The decision removes a barrier to entry, paving the way for more accessible and affordable blood glucose monitoring solutions for consumers.
[Read More](https://www.patentlyapple.com/2025/02/a-federal-judge-has-invalidated-an-omni-medsci-patent-which-could-open-the-door-for-a-blood-glucose-solution-for-apple-watch.html)
💬 [HN Comments](https://news.ycombinator.com/item?id=43124436) (90)
A US judge recently ruled against a patent held by a company called Masimo, invalidating its claims on a blood glucose sensor technology. This decision has significant implications for the tech industry, particularly for Apple. The ruling centers on Masimo's patent, which covered a specific method for measuring glucose levels through the skin. The judge found that Masimo's claims were not novel enough to warrant patent protection.
The key outcome is that this opens the door for companies like Apple to develop and market their own non-invasive blood glucose monitoring technologies, potentially integrating them into devices like the Apple Watch. The absence of Masimo's patent removes a major legal hurdle and reduces the risk of litigation for companies pursuing similar technologies. This could lead to a surge in innovation and competition in the market for wearable health monitoring devices. The decision removes a barrier to entry, paving the way for more accessible and affordable blood glucose monitoring solutions for consumers.
[Read More](https://www.patentlyapple.com/2025/02/a-federal-judge-has-invalidated-an-omni-medsci-patent-which-could-open-the-door-for-a-blood-glucose-solution-for-apple-watch.html)
💬 [HN Comments](https://news.ycombinator.com/item?id=43124436) (90)